Towards selectivity? approaches to the design of new anti-tumour agents—I
Authors:
- Peter J. CoxPCPeter J. Cox
- Peter B. FarmerPFPeter B. Farmer
- 31 March 1977
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 4 (1) , 47-63
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Structure and activity relationships of platinum complexes with anti-tumour activityChemico-Biological Interactions, 1975
- Synthesis and tumor-uptake study of phosphate esters of polyhedral hydroxyboranesJournal of Medicinal Chemistry, 1975
- Application of β-D-glucuronides and glucose together suggests a new direction for cancer chemotherapyNature, 1974
- Enzyme activated anti-tumor agents conjugates of p-hydroxyaniline mustard as substrates for hydrolytic enzymesBiochemical Pharmacology, 1974
- The Growth of Human Tumours in Immunosuppressed Mice and Their Response to ChemotherapyBritish Journal of Cancer, 1974
- Cytotoxic Agents Designed To Be Selective for Liver Cancer2JNCI: Journal of the National Cancer Institute, 1973
- The selective concentration of sulphadiazine and related compounds in malignant tissueEuropean Journal of Cancer (1965), 1973
- Aryl-2-halogenoalkylamines—XXVI glucuronic, sulphuric and phosphoric esters ofBiochemical Pharmacology, 1972
- A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474British Journal of Cancer, 1971
- Aryl-2-halogenoalkylamines: XXV. Derivatives of sulphanilamide designed for selective deposition in neoplastic tissueEuropean Journal of Cancer (1965), 1968